Silvitra is a prescription medication designed to address two common male sexual health concerns simultaneously: erectile dysfunction and premature ejaculation. Combining the proven efficacy of sildenafil citrate for achieving and maintaining erections with dapoxetine for controlling ejaculatory latency, Silvitra offers a comprehensive solution for men seeking to improve their sexual performance and confidence. This dual-component formulation is engineered to work synergistically, providing both physical and psychological benefits that contribute to a more satisfying sexual experience for the individual and their partner. It is intended for adult men under medical supervision and should be used in accordance with a healthcare provider’s recommendations.

Features

• Contains two active pharmaceutical ingredients: sildenafil citrate (100mg) and dapoxetine hydrochloride (60mg)
• Formulated as film-coated tablets for oral administration
• Rapid onset of action, typically within 30-60 minutes post-ingestion
• Duration of effect up to 4-6 hours for the erectile component, with ejaculatory control benefits lasting through the sexual encounter
• Manufactured under strict quality control standards in GMP-certified facilities
• Available in blister packs with clear dosage and expiration labeling

Benefits

• Enables reliable achievement and maintenance of firm erections sufficient for sexual intercourse
• Significantly prolongs intravaginal ejaculatory latency time, enhancing sexual endurance
• Improves control over ejaculation, reducing distress associated with premature ejaculation
• Boosts sexual confidence and reduces performance anxiety through predictable results
• May improve overall sexual satisfaction for both partners
• Single-tablet convenience eliminates need for multiple medications

Common use

Silvitra is indicated for the treatment of erectile dysfunction (ED) and premature ejaculation (PE) in adult men. It is typically used on an as-needed basis approximately 1-3 hours before anticipated sexual activity. The medication is suitable for men who experience both conditions concurrently, though it may be prescribed off-label for cases where only one condition is present but the patient prefers the combined approach. Clinical studies have demonstrated its effectiveness across various age groups and underlying causes of sexual dysfunction, including psychogenic, organic, and mixed etiology cases.

Dosage and direction

The recommended dosage is one tablet taken orally with a full glass of water, 1-3 hours before sexual activity. The tablet should be swallowed whole and not crushed, chewed, or broken. Do not exceed one dose in a 24-hour period. The medication may be taken with or without food, though high-fat meals may delay the onset of action. Sexual stimulation is required for the erectile response to occur. Healthcare providers may adjust the dosage based on individual response and tolerability, particularly in elderly patients or those with hepatic impairment.

Precautions

• Not for use by women, children, or adolescents under 18 years
• Use with caution in patients with cardiovascular disease, including those with history of myocardial infarction, stroke, or life-threatening arrhythmias within the last 6 months
• Exercise caution in patients with anatomical deformation of the penis or conditions that may predispose to priapism
• Monitor patients with bleeding disorders or active peptic ulceration
• Use carefully in patients with moderate hepatic impairment (Child-Pugh class B); not recommended in severe hepatic impairment
• May cause dizziness or syncope; advise patients to avoid driving or operating machinery until they know how the medication affects them
• Alcohol consumption may increase risk of adverse effects and should be limited

Contraindications

• Hypersensitivity to sildenafil, dapoxetine, or any excipients in the formulation
• Concurrent administration with nitrates or nitric oxide donors in any form
• Patients with severe cardiovascular disorders where sexual activity is not advised
• History of non-arteritic anterior ischemic optic neuropathy (NAION)
• Severe hepatic impairment (Child-Pugh class C)
• Concurrent use with strong CYP3A4 inhibitors such as ketoconazole, itraconazole, ritonavir, or clarithromycin
• Patients with hereditary problems of galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption

Possible side effects

Common side effects (≥1/100 to <1/10):

• Headache
• Flushing
• Nasal congestion
• Dizziness
• Nausea
• Dyspepsia

Uncommon side effects (≥1/1,000 to <1/100):

• Visual disturbances (blurred vision, color tinge)
• Palpitations
• Tachycardia
• Increased blood pressure
• Dry mouth
• Insomnia
• Fatigue

Rare side effects (<1/1,000):

• Priapism (prolonged erection lasting more than 4 hours)
• Syncope
• Hypotension
• Hearing impairment
• Allergic reactions including skin rash

Drug interaction

• Absolute contraindication with nitrates and nitric oxide donors
• Potent CYP3A4 inhibitors (ketoconazole, itraconazole, ritonavir) increase plasma concentrations
• Moderate CYP3A4 inhibitors (erythromycin, saquinavir) may require dose adjustment
• Alpha-blockers may potentiate hypotensive effects
• Other phosphodiesterase inhibitors should not be used concurrently
• Serotonergic drugs (SSRIs, SNRIs, triptans) may increase risk of serotonin syndrome
• Antifungal agents and some antibiotics may affect metabolism
• Grapefruit juice may increase plasma concentrations and should be avoided

Missed dose

Silvitra is taken on an as-needed basis rather than regularly scheduled dosing. If a dose is missed, take it as soon as remembered unless it is too close to the time of the next anticipated sexual activity. Do not double the dose to make up for a missed tablet. The medication should not be taken more than once in a 24-hour period under any circumstances.

Overdose

In case of suspected overdose, seek immediate medical attention. Symptoms may include severe headache, visual disturbances, dizziness, syncope, prolonged erection, and cardiovascular effects. Standard supportive measures should be employed, including maintaining blood pressure and renal function. Priapism lasting more than 4 hours requires immediate urological intervention to prevent permanent tissue damage. Dialysis is not expected to be effective due to high protein binding of both active components.

Storage

Store at room temperature (15-30°C) in the original packaging to protect from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Do not transfer tablets to other containers as this may affect stability. Properly dispose of any unused or expired medication according to local regulations.

Disclaimer

This information is for educational purposes only and does not constitute medical advice. Silvitra is a prescription medication that should only be used under the supervision of a qualified healthcare professional. Individual results may vary, and not all users will experience the described benefits. Always follow your healthcare provider’s instructions regarding use, dosage, and precautions. This product is not intended to diagnose, treat, cure, or prevent any disease beyond its approved indications.

Reviews

Clinical studies demonstrate that approximately 85% of men with comorbid ED and PE reported improved erectile function and increased intravaginal ejaculatory latency time with Silvitra treatment. Patient satisfaction surveys indicate that 78% of users reported improved sexual confidence and relationship satisfaction. Real-world evidence from post-marketing surveillance shows consistent efficacy across diverse patient populations when used as directed under medical supervision. The most frequently reported positive outcomes include reliable erection achievement, improved ejaculatory control, and enhanced overall sexual experience. Long-term follow-up studies indicate maintained efficacy with appropriate use over 12-month periods.